04/25/2024
3:30 PM | Revolution Medicines (Filer)
Revolution Medicines, Inc. (Filer)
| Form DEF 14A | |
04/25/2024
3:35 PM | Revolution Medicines (Filer)
Revolution Medicines, Inc. (Filer)
| Form DEFA14A | |
04/12/2024
7:08 PM | GOLDSMITH MARK A (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/12/2024
3:23 PM | Patel Sushil (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/10/2024
3:21 PM | GOLDSMITH MARK A (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/10/2024
3:21 PM | GOLDSMITH MARK A (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/10/2024
3:21 PM | GOLDSMITH MARK A (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
|
04/10/2024
3:21 PM | Patel Sushil (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/29/2024
3:57 PM | Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
Wei Lin (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
03/27/2024
3:24 PM | Cislini Jeff (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/20/2024
3:43 PM | Anders Jack (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/20/2024
3:44 PM | GOLDSMITH MARK A (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/20/2024
3:44 PM | Horn Margaret A (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/20/2024
3:45 PM | Kelsey Stephen Michael (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/20/2024
3:45 PM | Cislini Jeff (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/15/2024
4:50 PM | Horn Margaret A (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/15/2024
4:10 PM | Anders Jack (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/15/2024
4:21 PM | Cislini Jeff (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/15/2024
4:04 PM | Kelsey Stephen Michael (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/15/2024
3:48 PM | GOLDSMITH MARK A (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/13/2024
3:32 PM | Horn Margaret A (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
3:30 PM | Horn Margaret A (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/05/2024
3:52 PM | Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
Wang Xiaolin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2024
3:53 PM | Anders Jack (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2024
3:54 PM | Kelsey Stephen Michael (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2024
3:54 PM | Cislini Jeff (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2024
3:55 PM | GOLDSMITH MARK A (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2024
5:30 PM | EcoR1 Capital, LLC (Filed by)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
| Form SC 13G/A | |
02/14/2024
8:26 AM | BIOTECHNOLOGY VALUE FUND L P (Filed by)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
| Form SC 13G/A | |
02/13/2024
5:06 AM | BB BIOTECH AG (Filed by)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
| Form SC 13G/A | |
02/12/2024
4:11 PM | Farallon Capital Partners, L.P. (Filed by)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
| Form SC 13G/A | |
02/09/2024
4:22 PM | COLUMN GROUP III, LP (Filed by)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
| Form SC 13G/A | |
02/08/2024
9:17 AM | Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SC 13G/A | |
01/22/2024
3:18 PM | Cislini Jeff (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/10/2024
3:26 PM | Kelsey Stephen Michael (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/09/2024
1:15 PM | Revolution Medicines (Filer)
Revolution Medicines, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/04/2024
3:06 PM | Kelsey Stephen Michael (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/02/2024
3:31 PM | Kelsey Stephen Michael (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/29/2023
3:14 PM | Kelsey Stephen Michael (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/27/2023
3:22 PM | Kelsey Stephen Michael (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/20/2023
4:07 PM | Kelsey Stephen Michael (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS (Ad) You might have seen that Bitcoin was one of the best performing assets of 2023.
It gained 164%.
But a crypto millionaire who has been tracking the space for more than a decade has ABANDONED Bitcoin.
He found something better. Click here to find out that this 8,788% cryptocurrency is. |
12/20/2023
4:08 PM | Cislini Jeff (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/20/2023
4:08 PM | GOLDSMITH MARK A (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/20/2023
4:10 PM | Anders Jack (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/19/2023
6:30 PM | Horn Margaret A (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/15/2023
3:35 PM | Horn Margaret A (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/14/2023
5:38 PM | Horn Margaret A (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
| Form 144/A | |
12/14/2023
4:55 PM | GOLDSMITH MARK A (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/14/2023
5:14 PM | Kelsey Stephen Michael (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/14/2023
5:22 PM | Anders Jack (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/14/2023
4:48 PM | Cislini Jeff (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/14/2023
4:37 PM | Horn Margaret A (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/06/2023
3:33 PM | Horn Margaret A (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/20/2023
5:24 PM | Cislini Jeff (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/20/2023
3:14 PM | Cislini Jeff (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/16/2023
1:58 PM | Revolution Medicines (Filer)
Revolution Medicines, Inc. (Filer)
| Form CERT | |
11/15/2023
3:04 PM | Revolution Medicines (Filer)
Revolution Medicines, Inc. (Filer)
| Form 8-A12B | |
11/14/2023
7:13 PM | Horning Sandra (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
11/14/2023
7:13 PM | Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
Schroeder Thilo (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/14/2023
7:14 PM | Borisy Alexis (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/14/2023
7:15 PM | Horning Sandra (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/09/2023
4:18 PM | Farallon Capital Partners, L.P. (Filed by)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
| Form SC 13G | |
11/09/2023
12:26 PM | Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SC 13G/A | |
11/09/2023
8:20 AM | Revolution Medicines (Filer)
Revolution Medicines, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/06/2023
3:05 PM | Revolution Medicines (Filer)
Revolution Medicines, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/06/2023
3:09 PM | Revolution Medicines (Filer)
Revolution Medicines, Inc. (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/01/2023
6:11 AM | Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
| Form 425 | |
11/01/2023
6:15 AM | Revolution Medicines (Filer)
Revolution Medicines, Inc. (Filer)
| Form DEFA14A | |
11/01/2023
6:08 AM | Revolution Medicines (Filer)
Revolution Medicines, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/25/2023
5:20 PM | Horn Margaret A (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/24/2023
6:21 PM | GOLDSMITH MARK A (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/23/2023
5:01 PM | Anders Jack (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/23/2023
5:11 AM | Revolution Medicines (Filer)
Revolution Medicines, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/23/2023
5:13 AM | EQRx, Inc. (Subject)
EQRx, Inc. (Subject)
EQRx, Inc. (Subject)
EQRx, Inc. (Subject)
Revolution Medicines (Filed by)
Revolution Medicines, Inc. (Filed by)
| Form 425 | |
10/18/2023
3:23 PM | Horn Margaret A (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/16/2023
3:19 PM | Horn Margaret A (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/13/2023
3:20 PM | Kelsey Stephen Michael (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/13/2023
10:54 AM | Revolution Medicines (Filer)
Revolution Medicines, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/11/2023
3:05 PM | Kelsey Stephen Michael (Reporting)
Kelsey Stephen Michael (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/02/2023
3:12 PM | Cislini Jeff (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/01/2023
11:15 PM | Revolution Medicines (Filer)
Revolution Medicines, Inc. (Filer)
| Form EFFECT | |
09/29/2023
3:19 PM | Revolution Medicines (Filer)
Revolution Medicines, Inc. (Filer)
| Form DEFM14A | |
09/29/2023
3:19 PM | Revolution Medicines (Filer)
Revolution Medicines, Inc. (Filer)
| Form DEFM14A | |
09/29/2023
3:17 PM | Revolution Medicines (Filer)
Revolution Medicines, Inc. (Filer)
| Form 424B3 | |
09/28/2023
3:10 PM | Cislini Jeff (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/27/2023
4:25 PM | Revolution Medicines (Filer)
Revolution Medicines, Inc. (Filer)
| Form S-4/A | |
09/20/2023
3:12 PM | GOLDSMITH MARK A (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/20/2023
3:13 PM | Kelsey Stephen Michael (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/20/2023
3:11 PM | Anders Jack (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/20/2023
3:11 PM | Cislini Jeff (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/20/2023
11:40 AM | Horn Margaret A (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
The Best AI Stock to Own in the World Today is Trading for Just $25 (Ad) “Titan of Tech” Bets Big on Tiny AI Company
He’s made as much as 3,250,000% in just three years on companies like Facebook, Airbnb, and PayPal…
But our research shows his latest investment could be his most successful venture yet. See how you can invest alongside him |
09/19/2023
8:41 PM | Cislini Jeff (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/19/2023
8:44 PM | GOLDSMITH MARK A (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/19/2023
8:24 PM | Kelsey Stephen Michael (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/19/2023
8:12 PM | Anders Jack (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/19/2023
3:17 PM | Horn Margaret A (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/15/2023
3:23 PM | Horn Margaret A (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/13/2023
4:20 PM | Revolution Medicines (Filer)
Revolution Medicines, Inc. (Filer)
| Form S-4
Registration statement under Securities Act of 1933 | |
09/06/2023
7:02 PM | Anders Jack (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/06/2023
7:03 PM | Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
Weber Barbara (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
